Literature DB >> 28573471

Emergence of Clostridium difficile tcdC variant 078 in Marseille, France.

N Cassir1, N Fahsi2, G Durand2, J-C Lagier2, D Raoult2, P-E Fournier3.   

Abstract

The purpose of this investigation was to evaluate the epidemiology of hypervirulent Clostridium difficile ribotypes from January 2013 to February 2017 in the Marseille area of southern France. By using the Xpert Clostridium difficile Epi polymerase chain reaction (PCR) assay and sequencing the tcdC gene, we characterised C. difficile isolates from symptomatic patients diagnosed with C. difficile infection (CDI) in Marseille university hospitals. We first tested retrospectively 278 C. difficile samples isolated from January 2013 to December 2014 and observed a high prevalence of isolates with tcdC mutations and deletions previously described in both hypervirulent ribotypes RT027 and RT078 (16.4% and 10.7%, respectively). We highlighted the co-circulation of these two hypervirulent C. difficile tcdC variants (tV) with distinct epidemiological characteristics. While an RT027 outbreak occurred mainly as healthcare-associated infection in the elderly, CDI caused by tV078 occurred mainly in a younger population as community-associated infection. From January 2016, a systematic survey of these two hypervirulent C. difficile ribotypes revealed the emergence of CDI caused by tV078, currently being more prevalent than RT027 in the Marseille area. The present study is the first report of the emergence of CDI caused by tV078 in southern France. We showed the simultaneous circulation and sequential spread of hypervirulent ribotypes, such as RT027 and tV078. This emphasises the need for an efficient surveillance system for CDI with ribotyping and an optimised management of CDI caused by hypervirulent strains.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28573471     DOI: 10.1007/s10096-017-3022-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.

Authors:  S B Debast; M P Bauer; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2014-03       Impact factor: 8.067

2.  Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype.

Authors:  Rossella Baldan; Alberto Trovato; Valentina Bianchini; Anna Biancardi; Paola Cichero; Maria Mazzotti; Paola Nizzero; Matteo Moro; Cristina Ossi; Paolo Scarpellini; Daniela Maria Cirillo
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

3.  A Regional Outbreak of Clostridium difficile PCR-Ribotype 027 Infections in Southeastern France from a Single Long-Term Care Facility.

Authors:  Nadim Cassir; Jean-Christophe Delarozière; Gregory Dubourg; Marion Delord; Jean-Christophe Lagier; Phillipe Brouqui; Florence Fenollar; Didier Raoult; Pierre Edouard Fournier
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-03       Impact factor: 3.254

Review 4.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Host and pathogen factors for Clostridium difficile infection and colonization.

Authors:  Vivian G Loo; Anne-Marie Bourgault; Louise Poirier; François Lamothe; Sophie Michaud; Nathalie Turgeon; Baldwin Toye; Axelle Beaudoin; Eric H Frost; Rodica Gilca; Paul Brassard; Nandini Dendukuri; Claire Béliveau; Matthew Oughton; Ivan Brukner; Andre Dascal
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

6.  Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates.

Authors:  F Barbut; P Mastrantonio; M Delmée; J Brazier; E Kuijper; I Poxton
Journal:  Clin Microbiol Infect       Date:  2007-09-11       Impact factor: 8.067

7.  Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain.

Authors:  Sze K Lim; Rhonda L Stuart; Kate E Mackin; Glen P Carter; Despina Kotsanas; Michelle J Francis; Marion Easton; Karolina Dimovski; Briony Elliott; Thomas V Riley; Geoff Hogg; Eldho Paul; Tony M Korman; Torsten Seemann; Timothy P Stinear; Dena Lyras; Grant A Jenkin
Journal:  Clin Infect Dis       Date:  2014-04-04       Impact factor: 9.079

8.  Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012.

Authors:  D W Eyre; L Tracey; B Elliott; C Slimings; P G Huntington; R L Stuart; T M Korman; G Kotsiou; R McCann; D Griffiths; W N Fawley; P Armstrong; K E Dingle; A S Walker; T E Peto; D W Crook; M H Wilcox; T V Riley
Journal:  Euro Surveill       Date:  2015-03-12

9.  Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; Rosalind M Harding; Lily O'Connor; David Griffiths; Ali Vaughan; John Finney; Mark H Wilcox; Derrick W Crook; Tim E A Peto
Journal:  PLoS Med       Date:  2012-02-07       Impact factor: 11.069

10.  Diverse sources of C. difficile infection identified on whole-genome sequencing.

Authors:  Derrick W Crook; Mark H Wilcox; Tim E A Peto; A Sarah Walker; David W Eyre; Madeleine L Cule; Daniel J Wilson; David Griffiths; Alison Vaughan; Lily O'Connor; Camilla L C Ip; Tanya Golubchik; Elizabeth M Batty; John M Finney; David H Wyllie; Xavier Didelot; Paolo Piazza; Rory Bowden; Kate E Dingle; Rosalind M Harding
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

View more
  4 in total

Review 1.  An Update on Clostridioides difficile Binary Toxin.

Authors:  Adrián Martínez-Meléndez; Flora Cruz-López; Rayo Morfin-Otero; Héctor J Maldonado-Garza; Elvira Garza-González
Journal:  Toxins (Basel)       Date:  2022-04-27       Impact factor: 5.075

2.  The duration of antibiotic treatment is associated with carriage of toxigenic and non-toxigenic strains of Clostridioides difficile in dogs.

Authors:  Carolina Albuquerque; Davide Pagnossin; Kirsten Landsgaard; Jessica Simpson; Derek Brown; June Irvine; Denise Candlish; Alison E Ridyard; Gillian Douce; Caroline Millins
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

3.  PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255.

Authors:  Anne J Gonzales-Luna; Travis J Carlson; Kierra M Dotson; Kelley Poblete; Gabriela Costa; Julie Miranda; Chris Lancaster; Seth T Walk; Shawn Tupy; Khurshida Begum; M Jahangir Alam; Kevin W Garey
Journal:  Emerg Microbes Infect       Date:  2020-02-10       Impact factor: 7.163

4.  Description of Clostridium cagae sp. nov., Clostridium rectalis sp. nov. and Hathewaya massiliensis sp. nov., new anaerobic bacteria isolated from human stool samples.

Authors:  M L Tall; C I Lo; E Kuete Yimagou; S Ndongo; T P T Pham; D Raoult; P-E Fournier; F Fenollar; A Levasseur
Journal:  New Microbes New Infect       Date:  2020-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.